CSG Partners Advises ESOP Transaction for Home Medical Equipment.

Mar 04, 2014, 06:45 ET from CSG Partners, LLC

NEW YORK, March 4, 2014 /PRNewswire/ --  CSG Partners, LLC, served as the exclusive financial advisor to Home Medical Equipment, on its recent transition to becoming 100% owned by its Employee Stock Ownership Plan (ESOP). 

Home Medical Equipment is a provider of custom mobility products, equipment, and services for the severely physically challenged in the greater New York Metropolitan area. Founded in 2003, the Company focuses on offering a broad array of quality solutions to physically challenged clients to maintain their mobility and accessibility in everyday life activities.

Stephen Berman, Managing Director who led the transaction team at CSG Partners, commented: "It was a privilege working with Home Medical. Not only is the ESOP a highly strategic liquidity structure for shareholders, it also provides exceptional benefits to employees and positions the Company for long term success. The ESOP will certainly enable Home Medical to build a strong ownership culture and ensure the Company's legacy.

Bill Tobia, President of Home Medical Equipment explained, "Our new ownership structure promises great things for the future of our company. It's a meaningful change for all of our hardworking, dedicated employees who now share ownership in the company they helped to build."


CSG Partners, LLC is a boutique investment bank specializing in ESOPs, mergers and acquisitions, and capital advisory services for middle-market companies. Our clients have spanned the full middle-market spectrum, with values ranging from $10 million to $600 million. Founded in 2001, the firm has built a reputation of having the nation's preeminent ESOP investment banking practice. The firm has closed over 140 ESOP transactions for companies with an aggregate value exceeding $9 Billion. CSG Partners operates from offices in New York and San Francisco. More information on the firm can be found at www.csgpartners.com, LinkedIn, and Twitter.